Lava Therapeutics grabs $83m Series C
Lava Therapeutics, a Dutch and U.S. biotech company, has raised $83 million in Series C funding.
Lava Therapeutics, a Dutch and U.S. biotech company, has raised $83 million in Series C funding.
Copyright PEI Media
Not for publication, email or dissemination